3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Smoking Cessation
1
Renal Insufficiency
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Hepatitis B
1
Hematuria
1
Fatigue
1
Carcinoma, Transitional Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Dexamethasone
8
Bortezomib
7
Cyclophosphamide
6
Lenalidomide
4
isatuximab
3
glucarpidase
3
Calcium Dobesilate
3
Thalidomide
2
Kidney Transplantation
2
Blood Specimen Collection
2
Bendamustine Hydrochloride
2
pomalidomide
1
gamma-Glutamyl Hydrolase
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
daratumumab
1
auricularum
1
Whole-Body Irradiation
1
Urination
1
Urinalysis
1
Stents
1
Standard of Care
1
Rituximab
1
Ranitidine
1
Nephrotomy
1
Nephrostomy, Percutaneous
1
Methotrexate
1
Leucovorin
1
Ice
1
Hematologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Renal Insufficiency
×
Urinalysis
×
Clear all
NCT04308642
2024-05-16
Kid-MaCareOnco
University Hospital, Basel, Switzerland
Completed
6 enrolled